Clinical Trials Browser

Phase 2 × Uterine Neoplasms × 90 days × Clear all

NCT05758688 2026-03-12

PROPS GYN

Phase 2 Recruiting

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT06369155 2026-03-02

Azenosertib in Uterine Serous Carcinoma: Biomarker Study

Phase 2 Recruiting

Uterine Neoplasms

NCT03668340 2026-01-12

AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma

Phase 2 Active not recruiting

Uterine Neoplasms